Potent α-amylase inhibitory activity of Indian Ayurvedic medicinal plants by P, Sudha et al.
RESEARCH ARTICLE Open Access
Potent a-amylase inhibitory activity of Indian
Ayurvedic medicinal plants
Sudha P
1†, Smita S Zinjarde
1†, Shobha Y Bhargava
2†, Ameeta R Kumar
1*†
Abstract
Background: Indian medicinal plants used in the Ayurvedic traditional system to treat diabetes are a valuable
source of novel anti-diabetic agents. Pancreatic a-amylase inhibitors offer an effective strategy to lower the levels
of post-prandial hyperglycemia via control of starch breakdown. In this study, seventeen Indian medicinal plants
with known hypoglycemic properties were subjected to sequential solvent extraction and tested for a-amylase
inhibition, in order to assess and evaluate their inhibitory potential on PPA (porcine pancreatic a-amylase).
Preliminary phytochemical analysis of the lead extracts was performed in order to determine the probable
constituents.
Methods: Analysis of the 126 extracts, obtained from 17 plants (Aloe vera (L.) Burm.f., Adansonia digitata L., Allium
sativum L., Casia fistula L., Catharanthus roseus (L.) G. Don., Cinnamomum verum Persl., Coccinia grandis (L.) Voigt.,
Linum usitatisumum L., Mangifera indica L., Morus alba L., Nerium oleander L., Ocimum tenuiflorum L., Piper nigrum L.,
Terminalia chebula Retz., Tinospora cordifolia (Willd.) Miers., Trigonella foenum-graceum L., Zingiber officinale Rosc.) for
PPA inhibition was initially performed qualitatively by starch-iodine colour assay. The lead extracts were further
quantified with respect to PPA inhibition using the chromogenic DNSA (3, 5-dinitrosalicylic acid) method.
Phytochemical constituents of the extracts exhibiting≥ 50% inhibition were analysed qualitatively as well as by
GC-MS (Gas chromatography-Mass spectrometry).
Results: Of the 126 extracts obtained from 17 plants, 17 extracts exhibited PPA inhibitory potential to varying
degrees (10%-60.5%) while 4 extracts showed low inhibition (< 10%). However, strong porcine pancreatic amylase
inhibitory activity (> 50%) was obtained with 3 isopropanol extracts. All these 3 extracts exhibited concentration
dependent inhibition with IC50 values, viz., seeds of Linum usitatisumum (540 μgml
-1), leaves of Morus alba (1440
μgml
-1) and Ocimum tenuiflorum (8.9 μgml
-1). Acarbose as the standard inhibitor exhibited an IC50 (half maximal
inhibitory concentration)value of 10.2 μgml
-1. Phytochemical analysis revealed the presence of alkaloids, tannins,
cardiac glycosides, flavonoids, saponins and steroids with the major phytoconstituents being identified by GC-MS.
Conclusions: This study endorses the use of these plants for further studies to determine their potential for type 2
diabetes management. Results suggests that extracts of Linum usitatisumum, Morus alba and Ocimum tenuiflorum
act effectively as PPA inhibitors leading to a reduction in starch hydrolysis and hence eventually to lowered
glucose levels.
Background
DM (Diabetes mellitus) is a metabolic disorder charac-
terized by chronic hyperglycemia or increased blood
glucose levels with disturbances in carbohydrate, fat and
protein metabolism resulting from absolute or relative
lack of insulin secretion [1]. The frequency of this disor-
der is on the rise globally, is likely to hit 300 million by
2025 with India projected to have the largest number of
diabetic cases [2].
Type 2 diabetes is one of the primary threats to
human health due to increasing prevalence, chronic
course and disabling complications [3]. Many diverse
therapeutic strategies for the treatment of Type 2 dia-
betes are in use. The conventional available therapies
for diabetes include stimulation of endogenous insulin
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target tissues, oral hypoglycemic agents, such as bigua-
nids and sulfonylureas and the inhibition of degradation
of dietary starch by glycosidases such as a-amylase and
a-glucosidase [4].
Pancreatic a-amylase (E.C. 3.2.1.1) is a key enzyme in
the digestive system and catalyses the initial step in
hydrolysis of starch to a mixture of smaller oligosac-
charides consisting of maltose, maltotriose, and a num-
ber of a-(l-6) and a-(1 - 4) oligoglucans. These are then
acted on by a-glucosidases and further degraded to glu-
cose which on absorbtion enters the blood-stream.
Degradation of this dietary starch proceeds rapidly and
leads to elevated PPHG (post-prandial hyperglycemia). It
has been shown that activity of HPA (human pancreatic
a-amylase) in the small intestine correlates to an
increase in post-prandial glucose levels, the control of
which is therefore an important aspect in treatment of
type 2 diabetes [5]. Hence, retardation of starch diges-
tion by inhibition of enzymes such as a-amylase plays a
key role in the control of diabetes. Inhibitors of pancrea-
tic a-amylase delay carbohydrate digestion causing a
reduction in the rate of glucose absorption and lowering
the post-prandial serum glucose levels [6]. Some inhibi-
tors currently in clinical use are acarbose and miglitol
which inhibit glycosidases such as a-glucosidase and a-
amylase while others such as and voglibose inhibit a-
glucosidase. However, many of these synthetic hypogly-
cemic agents have their limitations, are non-specific,
produce serious side effects and fail to elevate diabetic
complications. The main side effects of these inhibitors
are gastrointestinal viz., bloating, abdominal discomfort,
diarrhea and flatulence [7]. Herbal medicines are getting
more importance in the treatment of diabetes as they
are free from side effects and less expensive when com-
pared to synthetic hypoglycemic agents [8,9].
In India, indigenous herbal remedies such as Ayur-
veda and other Indian traditional medicine have since
ancient times used plants in treatment of diabetes [10].
Ethnobotanical studies of traditional herbal remedies
used for diabetes have identified more than 1,200 spe-
cies of plants with hypoglycemic activity [3,11].
A number of medicinal plants and their formulations
are used for treating diabetes in the traditional Indian
Ayurvedic system as well as in ethnomedicinal prac-
tices. Even though, these traditional practices are
empirical in nature, over 200 million people in India
with limited access to primary healthcare centres,
depend on traditional system of medicine to cater to
their healthcare needs [12]. However, this traditional
knowledge, derived empirically, has to be supported by
scientific testing. WHO (World Health Organization)
(1980) has recommended the evaluation and mechanistic
properties of the plants effective in such systems [13,14].
The search for new pharmacologically active agents
obtained by screening natural sources such as medic-
inal plants or their extracts can lead to potent and spe-
cific inhibitors for a-amylase [6]. Pharmacological
properties a-glucosidase inhibitors such as acarbose
that can also inhibit pancreatic a-amylase revealed that
the complications of DM such as onset of renal, ret-
inal, lens and neurological changes and the develop-
ment of ischaemic myocardial lesions are prevented or
delayed [15]. Long-term day-to-day management of
diabetes, with acarbose is well tolerated and can
improve glycaemic control asm o n o t h e r a p y ,a sw e l la s
in combination therapy [16].
The Western Ghat area in the western region of
India was declared an ecological hotspot in 1988 by
the Government of India. Though this area covers
barely five percent of India’s land, 27% of all species of
higher plants in India are found here. Some plants
found here such as Aloe vera (L.) Burm.f., Adansonia
digitata L., Allium sativum L., Casia fistula L., Cathar-
anthus roseus (L.) G. Don., Cinnamomum verum Persl.,
Coccinia grandis (L.) Voigt., Linum usitatisumum L.,
Mangifera indica L., Morus alba L., Nerium oleander
L . ,O c i m u mt e n u i f l o r u mL . ,P i p e rn i g r u mL . ,T e r m i n a -
lia chebula Retz., Tinospora cordifolia (Willd.) Miers.,
Trigonella foenum-graceum L., Zingiber officinale Rosc.
are well known in Ayurveda to possess anti-diabetic
properties [8,9,17-21]. These plants are known to
lower blood glucose levels and their traditional uses
are listed in Table 1. So far, reports on the systematic
evaluation and scientific investigation of these ant-
diabetic plants or their phytoconstituents pancreatic
a-amylase inhibitors are scarce. This study was carried
out not only to validate the traditional uses of these
plants in diabetes but also to initiate search for newer
pharmacophores with specificity towards pancreatic
a-amylase. Structurally as well as mechanistically, PPA
(Porcine pancreatic a-amylase) is closely related to
HPA (Human pancreatic a-amylase) [22]. Hence,
sequential solvent extracts of the abovementioned
plants were screened for the presence of PPA inhibi-
tors, the lead extracts quantified for PPA inhibition
under in vitro conditions and subjected to phytochem-
ical analysis in order to identify the probable inhibitory
phytoconstituents.
Methods
Material
Chemicals such as soluble starch, PPA (porcine pancreatic
a-amylase), methanol, isopropanol, acetone, methyl-
butyl-tertiary ether, cyclohexane and DMSO (dimethyl-
sulfoxide) were purchased from SRL Pvt. Ltd, Mumbai,
India. DNSA (3, 5-dinitrosalicylicacid) was obtained
from HiMedia Laboratories, Mumbai, India. Acarbose
P et al. BMC Complementary and Alternative Medicine 2011, 11:5
http://www.biomedcentral.com/1472-6882/11/5
Page 2 of 10was purchased from Sigma Aldrich, USA. All other che-
micals procured were from local manufacturer and were
of AR grade.
Plant material
The above mentioned anti-diabetic plants were collected
from the Western Ghats, Maharashtra State, India in
the months of August-January. Herbarium specimen of
each these plants was submitted to Botanical Survey of
India, Pune for authentication. The voucher numbers
are specified in additional file 1. Plant name, family,
parts used along with its hypoglycemic and medicinal
properties are listed in Table 1.
Preparation of plant extracts
Air-dried plant material was finely crushed, powdered
and successively extracted in polar to non-polar solvent
on an increasing degree of non-polarity. The solvents
used in sequential order were cold water, hot water,
methanol, isopropanol, acetone, methyl-butyl-tertiary
ether and cyclohexane. The significance of sequential
extraction from polar to non-polar solvent is the fact
that traditional Ayurvedic methods of preparing herbal
formulations are mainly aqueous. It is also likely that
peptides, proteins or glycans possessing a-amylase inhi-
bitory activity would be extracted in aqueous system
which would otherwise be denatured during organic
Table 1 Plant sources and their traditional uses
Plants Name Family Parts
used
Hypoglycemic and medicinal properties Ref.
Adansonia digitata L. Bombacaceae Leaves Lowers blood glucose level due to insulin like effect on peripheral tissues; by
promoting glucose uptake and metabolism or by inhibiting hepatic
gluconeogenesis
[18]
Allium sativum L. Alliaceae Rhizomes Lowers blood pressure and improves lipid profile, decreases serum glucose,
triglycerides, cholesterol, urea, uric acid, increases serum insulin levels
[40]
Aloe vera (L.) Burm.f. Liliace Leaf Gel Hypoglycemic activity, decreases fasting glucose levels, hepatic transaminases,
plasma and liver cholesterol, triglycerides, free fatty acids and phospholipids.
Improves plasma insulin level. Restores normal levels of LDL and HDL and
cholesterol Reduces levels of hepatic phosphatidylcholine hydroperoxide and
have hypocholesterimic efficacy, diminishes degenerative changes observed in
kidney tissues
[41]
Casia fistula L. Caesalpiniaceae Leaves Hypoglycemic activity decreases blood glucose level [19]
Catharanthus roseus (L.). G. Don Apocynaceae Leaves Reduces blood glucose by enhancing secretion of insulin from b-cells of
Langerhans or through extra pancreatic mechanism
[42]
Cinnamomum verum Persl. Lauraceae Bark Reduces the blood glucose and elevates the plasma insulin level. [43]
Coccinia grandis (L.) Voigt. Cucurbitacea Fruit Reduces blood glucose and glycosylated hemoglobin content. C. indica
extracts lowers blood glucose by depressing its synthesis, depression of
glucose 6-phosphatase and fructose1,6, bisphosphatase and enhancing glucose
oxidation by shunt pathway through activation of iglucose 6-phosphate
dehydrogenase
[44]
Linum usitatisumum L. Linaceae Seeds Reduces fasting blood sugar levels, total cholesterol; reduces carbohydrate
absorption from gut and clinical symptoms of diabetes associated with
dyslipidamia.
[20]
Mangifera indica L. Anacardiaceae Fruit,
Leaves
Reduces glucose absorption in type 2 diabetes. Stimulates glycogenesis in liver
causing reduction in blood glucose level.
[45]
Morus alba L. Moraceae Leaves Antiphlogistic, diuretic, expectorant and antidiabetic. Increases the b-cell
number in diabetic islets. Reduces levels of glycosylated hemoglobin.
Decreases triglycerides, cholesterol and VLDL to normal levels in type II DM
patients. Restores elevated levels of blood urea.
[46]
Nerium oleander L. Apocynaceae Leaves Clorogenic acid, querecetin and cathechin induce post prandial hyperglycemia
by acting as a-glucosidase inhibitors.
[21]
Ocimum tenuiflorum L. Laminaceae Leaves Lowers blood glucose level, modulates cellular antioxidant defense system.
Improves b cell function and enhances insulin secretion. Inhibits absorption of
glucose from the intestine
[47]
Piper nigrum L. Piperaceae Seeds Reduces glucose and serum lipid levels [48]
Terminalia chebula Retz. Combretaceae Fruit Decreases blood glucose levels by enhancing secretion of insulin from b cells
of Langerhans or through extra pancreatic mechanism. Inhibits advanced
glycosylation end products, which contribute to renal damage.
[49]
Tinospora cordifolia (Willd.) Miers Menispermaceae Stem Decreases blood glucose level through glucose metabolism. It exhibits
inhibitory effect on adrenaline-induced hyperglycemia.
[50]
Trigonella foenum-graceum L. Fabaceae Seeds Decreases s post prandial blood glucose level. [51]
Zingiber officinale Rosc. Zingiberaceae Rhizome Lowers plasma glucose level [52]
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water extracts were obtained by adding water to the
crushed material in a ratio of 1:4 (w/v) and kept at 30°C
(24 h) and 55°C (2 h) at130 rpm respectively. Each of
the extract was filtered, centrifuged and the residue col-
lected was subjected to subsequent solvent extraction.
The organic solvents were added in a ratio of 1:3 (w/v)
and refluxed with the residue for 3 h at their respective
boiling temperatures. The extracts collected were fil-
tered and stored at -20°C. Before assay, the organic fil-
trates were concentrated in vacuo in a rotary evaporator
at 50°C while the aqueous extracts were lyophilized.
Stock solutions for inhibition assay were prepared by
d i s s o l v i n gu pt o1 . 5m go fe a c he x t r a c ti n1m lo f
DMSO and appropriately diluting it before use.
Pancreatic a-amylase inhibition assays
Starch-Iodine colour assay
Screening of plant material for a-amylase inhibitors was
carried out in a microtitre plate according to Xiao et al
(2006) based on the starch-iodine test [23]. The total
assay mixture composed of 40 μl 0.02 M sodium phos-
phate buffer (pH 6.9 containing 6 mM sodium chloride),
0.02 units of PPA solution and plant extracts at concen-
tration from 0.1-1.5 mgml
-1 (w/v) were incubated at
37°C for 10 min. Then soluble starch (1%, w/v) was
added to each reaction well and incubated at 37°C for
15 min. 1 M HCl (20 μl) was added to stop the enzy-
matic reaction, followed by the addition of 100 μlo f
iodine reagent (5 mM I2 and 5 mM KI). The colour
change was noted and the absorbance was read at 620
nm on a microplate reader. The control reaction repre-
senting 100% enzyme activity did not contain any plant
extract. To eliminate the absorbance produced by plant
extract, appropriate extract controls without the enzyme
were also included. The known PPA inhibitor, acarbose,
was used a positive control at a concentration range of
6.5 - 32.8 μgml
-1. A dark-blue colour indicates the pre-
sence of starch; a yellow colour indicates the absence of
starch while a brownish colour indicates partially
degraded starch in the reaction mixture. In the presence
of inhibitors from the extracts the starch added to the
enzyme assay mixture is not degraded and gives a dark-
blue colour complex whereas no colour complex is
developed in the absence of the inhibitor, indicating that
starch is completely hydrolysed by a-amylase.
3, 5-dinitrosalicylic acid assay
The inhibition assay was performed using the chromo-
genic DNSA method [24]. The total assay mixture
composed of 500 μl of 0.02 M sodium phosphate
buffer (pH 6.9 containing 6 mM sodium chloride),
0.04 units of PPA solution and extracts at concentration
from 0.1-1.5 mgml
-1(w/v) were incubated at 37°C for 10
min. After pre-incubation, 500 μl of 1% (v/v) starch
solution in the above buffer was added to each tube and
incubated at 37°C for 15 min. The reaction was termi-
nated with 1.0 ml DNSA reagent, placed in boiling
water bath for 5 min, cooled to room temperature,
diluted and the absorbance measured at 540 nm. The
control PPA at 0.21 Uml
-1 represented 100% enzyme
activity and did not contain any plant extract. To elimi-
nate the absorbance produced by plant extract, appro-
priate extract controls with the extract in the reaction
mixture except for the enzyme were also included. The
known PPA inhibitor acarbose was used a positive con-
trol at a concentration range of 6.5 - 32.8 μgml
-1.
One unit of enzyme activity is defined as the amount
of enzyme required to release one micromole of maltose
from starch per min under the assay conditions.
The IC50 values were determined from plots of per-
cent inhibition versus log inhibitor concentration and
calculated by logarithmic regression analysis from the
mean inhibitory values. The IC50 values were defined as
the concentration of the extract, containing the a-amy-
lase inhibitor that inhibited 50% of the PPA activity.
The other quantifiers were calculated as follows:
%/ Relative enzyme activity enzyme activity of test enzyme a = c ctivity of control () *. 100
%% inhibition in the  amylase activity relative enzyme  −= − 100    activity () .
Preliminary Phytochemical Analysis
The lead extracts were subjected to qualitative phyto-
chemical analysis while the identification of the major
phytoconstituents was carried out using GC-MS.
Qualitative phytochemical analysis
Lead extracts positive for a-amylase inhibition were
tested for the presence of proteins, alkaloids, tannins,
saponins, cardiac glycosides, steroids and flavonoids in
accordance to Parekh and Chanda and Trease and
Evans (1989) [25,26].
GC-MS Analysis
Analysis of the lead organic extracts exhibiting ≥50%
inhibition on the PPA activity were performed on a
GCMS-MS (HEWLETT PACKARD, GCD-1800 A) gas
chromatograph equipped with DB 5 ms capillary col-
umn (30 m × 0.25 mm ID). Helium was the carrier gas
with flow rate of 1 mL/min, the injector mode- split
(1:60), the injection volume 1 μL, the temperature pro-
gram used is as follows: 80°C (3 min), then increased to
280°C at 10°C/min, held at 280°C (10 min) and tempera-
ture scan, m/z 35-300 amu. Appropriate solvent controls
were also run. The identification of the components was
based on the comparison of their mass spectra with
those of NIST-Wiley 2008 library.
Statistical Data Analysis
All experiments were performed in 3 different sets with
each set in triplicates. The data are expressed as mean ±
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was performed for ANOVA (analysis of variance) fol-
lowed by F test using SPSS version 11.5. Values of p
which were ≤ 0.05 were considered as significant.
Results and Discussion
Drugs that reduce post-prandial hyperglycaemia by sup-
pressing hydrolysis of starch such as PPA inhibitors
have been found useful in the control of diabetes melli-
tus [27,28]. Many herbal extracts have been reported for
their anti-diabetic activities and are currently being used
in Ayurveda for the treatment of diabetes. However,
such medicinal plants have not gained much importance
as medicines due to the lack of sustained scientific
evidence.
In the present study, seventeen indigenous antidiabetic
medicinal plants from the Western Ghats of India were
screened for their a-amylase inhibitory potential. Plants
used in the study along with the parts used and their
hypoglycemic properties are listed in Table 1 while their
voucher numbers are listed as an additional file 1. Sev-
eral studies performed on these plants state them to be
hypoglycemic, but none of these plants have been stu-
died or tested for pancreatic a-amylase inhibitors in
order to justify their hypoglycemic property. The ratio-
nale for performing extractions from polar to non-polar
solvents is to confirm and validate the inhibitory activity
in the aqueous extractions performed in the traditional
manner as well as to search for newer, more potent
inhibitory compounds in the organic solvents. Primary
screening for a-amylase inhibition was performed based
on starch-iodine colour complex formation. Upon
extraction a total of 126 extracts were obtained from 17
plants. Of these 126 extracts screened, 21 extracts tested
positive for PPA inhibition (Table 2). These lead
extracts were further quantified with respect to PPA
inhibition by chromogenic DNSA method and it was
noted that 4 extracts exhibited low (< 10%) while 17
extracts showed significant (p value ≤ 0.05) PPA inhibi-
tory activity (10 - 60.5%).
The aqueous extracts, i.e., cold water extracts of
A. vera,a n dT. foenum exhibited 23.3%, and 13.4% inhi-
bition at concentration of 2.5 mgml
-1 and 1.5 mgml
-1
respectively. Low inhibitory potential (p value ≤ 0.1) was
observed for hot water extracts of T. foenum (10.8%) at
a concentration of 3.5 mgml
-1. Methanol extracts of
C. fistula showed 29.2% PPA inhibition followed by
M. alba (15.1%) and T. foenum (11.8%) at 1.9 mgml
-1,
3.9 mgml
-1 and 5.2 mgml
-1, respectively. Significant (p <
0.05) and strong PPA inhibition was observed for
isopropanol extracts of M. alba (60.5%)at 1.8 mgml
-1,
L. usitatisumum (55.7%) at 0.65 mgml
-1 and O. tenui-
florum (53.4%) at 0.0094 mgml
-1 whereas low inhibition
was noted in the case of C. fistula (10.0%) at 2.4 mgml
-1
and T. foenum (13.2%) at 3.6 mgml
-1. Acetone extracts
of L. usitatisumum (33.5%) exhibited moderate PPA
inhibition (p value ≤ 0.05) at a concentration of
2.6 mgml
-1. Methyl-tertiary-butyl ether extracts of C. fis-
tula (18.9%) and L. usitatisumum (39.1%) showed PPA
inhibitory activity at 3.4 mgml
-1 and 2.7 mgml
-1, while
cyclohexane extracts of C. fistula (25.2%), T. foenum
(19.3%) and A. vera (15.8%) also showed moderate PPA
inhibitory activity at 5.7 mgml
-1,1 . 9m g m l
-1 and
2.4 mgml
-1, respectively (p value ≤ 0.1) (Figure 1). All
the other extracts showed no significant PPA inhibitory
activity (Table 2, Figure 1). None of the extracts were
found to enhance PPA activity.
Thus of the abovementioned extracts only three viz;
L. usitatisumum, M. alba and, O. tenuiflorum isopropanol
extracts exhibited strong i.e., ≥ 50% inhibition against
PPA. Concentration dependent incubation of these isopro-
panol plant extracts of L. usitatisumum(0.5-2.6 mgml
-1),
M. alba (0.3-1.8 mgml
-1)a n dO. tenuiflorum (0.001-
0.009 mgml
-1), respectively with a-amylase and starch
Table 2 Inhibition of PPA activity based on starch-iodine
color assay by solvent extracts
a of different plants at
0.1-1.5 mgml
-1 (w/v)
Plant Species Extracts
CWE HWE ME IPE AE MTBE CHE
A. digitata (Leaves) - - - - - - -
A. sativum (Rhizomes) - - - - - - -
A. vera (Leaf Gel) + - - - - - +
C. fistula (Leaves) + + + + - + +
C. roseus (Leaves) - - - - - - -
C. verum (Bark) - - - - - - -
C. indica. (Fruit) - - - - - - -
L. usitatisumum (Seeds) - - - + + + -
M. indica (Leaves) - - - - - - -
M. indica (Fruit) - - - - - - -
M. alba (Leaves) - - + + - - -
N. indicum (Leaves) - - - - - - -
O. tenuiflorum (Leaves) - - - + - - -
P. nigrum (Seed) - - - - - - -
T. chebula (Fruit) - - - - - - -
T. cordifolia (Stem) - - - - - - -
T. foenum (Seeds) + + + + + + +
Z. officinallis (Rhizomes) - - - - - - -
Acarbose (6.5 - 32.8 μgml
-1)+
a Extracts were sequentially prepared as described in Methods.
+: Inhibition.
-: No Inhibition.
CWE: Cold water Extract.
HWE: Hot water Extract.
ME: Methanol Extract.
IPE: Isopropanol Extract.
AE: Acetone Extract.
MTBE: Methyl-tertiary-butyl Ether Extract.
CHE: Cyclohexane Extract.
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the enzyme activities from 0.21 U to 0.09 U. A dose
dependent effect was observed on increasing the con-
centrations of the extract solution, suggesting a compe-
titive type of inhibition. Plots of percent inhibition vs
log concentration of extracts showed typical sigmoidal
dose response curves (Figure 2). It was noted that the
IC50, values i.e.,50% inhibition occurred at
concentrations of 540 μgml
-1,1 4 4 0μgml
-1,8 . 9μgml
-1
for L. usitatisumum, M. alba, O. tenuiflorum,
respectively. Acarbose was taken as a positive control
with an IC50 value at 10.2 μgml
-1. O. tenuiflorum isopro-
panol extract exhibited an IC50 value less than acarbose
suggesting that it could be a promising lead extract.
It could thus be speculated that these 3 extracts
possess significant PPA inhibiting activity. Phytochem-
ical analysis of these isopropanol extracts revealed the
presence of alkaloids, steroids, saponins and cardiac
glycosides in L. usitatisumum. Tannins, cardiac glyco-
sides, flavonoids and saponins were detected in M. alba
Figure 1 The percent relative enzyme activity (RA %) of porcine pancreatic a-amylase (PPA) on inhibition with different extracts.( a )
Cold water extracts-CWE (b) Hot water extracts-HWE (c) Methanol extracts-ME (d) Isopropanol extracts-IPE (e) Methyl-tertiary-butyl-ether extacts-
MTBE (f) Cyclohexane extracts-CHE of the listed plants. Pure porcine pancreatic a-amylase serves as control. The data is indicated as the mean ±
SEM; (n = 3). The students F-test was used and the bars with different asterisks (***, **, *) show significant difference with respect to control (P <
0.05). 1 Control 2 A. vera 3 C. fistula 4 L. usitatisumum 5 M. alba 6 O. tenuiflorum 7 T. foenum.
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loids, tannins and flavonoids (Table 3).
Preliminary GC-MS analysis based on retention time
and molecular mass was performed to determine the
nature of these phytoconstituents (Table 4). It was
n o t e dt h a ti nL. usitatisumum seed isopropanol extract
the major compound detected could either be 2-cyclo-
pentene-1-undecanoic acid (hydnocarpic acid) or
cyclopentane undecanoic acid (dihydrohydnocarpic
acid). The other compounds were in too low a concen-
tration to be correctly identified. Such natural cyclic
fatty acids are found in seeds from species of plants
belonging to Flacourtiaceae family [29]. It has also been
suggested that on heating of vegetal oils several fatty
acids containing cyclopentnyl or cyclohexanyl ring are
formed from linoleic and linolenic acids [30], under
conditions similar to those used for solvent extraction.
It has also been shown that compounds like linoleic and
a-linoleic acids as well as lignin glycosides are present
in L. usitatisumum seeds [31]. In our previous report,
we have shown that Linum usitatissimum extract could
significantly inhibit crude preparations of glycosidases
isolated from murine pancreas but not from the liver or
small intestines [32]. Hence, this extract seems to pos-
sess potential PPA inhibitory activity and could be a
good candidate to carry out further in vivo studies.
The major phytoconstituents detected in the leaf iso-
propanol extract of M. alba were naphthalene, hexade-
conoic (palmitic acid) and 9, 12-octadecadienoic acid
(9,12-linoleic acid). These compounds have also been
detected in M.alba leaves by earlier researchers [33].
Figure 2 The percent Porcine Pancreatic a-amylase inhibition (%) of different extracts at varying concentrations. The data is indicated
as the mean ± SEM; (n = 3). (P < 0.05). IPE - Isopropanol Extract.
Table 3 Qualitative phytochemical analysis of
isopropanol extracts exhibiting ≥ 50% inhibition on PPA
activity
Plant Species L. usitatisumum M. alba O. tenuiflorum
Proteins -- -
Alkaloids +- +
Tannins -+ +
Cardic glycosides ++-
Flavinoids -+ +
Saponins ++-
Steroids +--
+ Detected.
- Not detected.
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and 1-DNJ (1-deoxynojirimycin) in methanol extracts of
M.alba leaves from China. 1-DNJ is a known inhibitor
of a- glucosidase and a-amylase [34]. However, the
methanol extract in our study showed relatively low
PPA inhibitory activity (15.1%) as compared to the iso-
propanol extract (60.5%).
The major compounds identified from the leaf extract
of O. tenuiflorum, were camphene, methyleugenol and
2-heptanol, 5-ethyl-. These monoterpenes, phenyl pro-
panoids and alcohols have been reported earlier from
Ocimum s p .[ 3 5 - 3 7 ] .O r a la d m i n i s t r a t i o no fe t h a n o l i c
extracts of O. tenuiflorum were found to reduce serum
glucose levels in normal and streptozotocin induced dia-
betic rats [38]. Essential oils obtained from Cedrus
libani were found to inhibit a-amylase activity with an
IC50 value of 0.14 mg/ml [39]. One of the compounds
in this oil was identified as camphene, similar to that
detected in O. tenuiflorum. Our earlier study [32] has
also shown that O. tenuiflorum extracts possessed signif-
icant inhibitory activity against isolated glycosidase pre-
parations obtained from murine pancreatic, liver and
small intestinal tissues.
These findings suggest that one of the mechanisms by
which L. usitatisumum, M. alba and O. tenuiflorum
could be exhibiting their hypoglycemic effect would be
by inhibition of PPA activity leading to retardation of
starch hydrolysis, eventually lowering PPHG. All the
phytoconstituents have earlier been reported from these
plants but none of them have shown to possess PPA
inhibitory activity. Since, the nature of the phytochem-
ical responsible for PPA inhibitory activity has not yet
been ascertained, the active principle(s) needs to be iso-
lated and characterized through in vitro and in vivo stu-
dies. While some anti-diabetic plants in this study
showed negligible inhibition against PPA, 17 extracts
exhibited moderate to good enzyme inhibitory activity.
Hence, though multiple mechanisms exist by which
these plants could affect their hypoglycemic potential,
one of the mechanisms by which some of these plants
could be lowering PPHG levels could be due to PPA
inhibition.
Conclusions
Since the Indian population has long been using all the
3 plants for food and medicinal purposes, they form a
part of the local pharmacopoeia. Our results suggest
that one of the targets for hypoglycaemic property of
L. usitatisumum, M. alba and O. tenuiflorum is pancrea-
tic a-amylase inhibition. However, isolation and charac-
terization of the compounds responsible for this
inhibitory activity as well as in vivo studies need to be
performed to confirm these observations. These phyto-
chemical(s)/bioactive principle from the plants responsi-
ble for the PPA inhibition are currently being isolated
and characterized.
Additional material
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Table 4 GCMS Profile of extracts exhibiting ≥ 50% inhibition on PPA activity
Name of the plant Name of the compound Molecular
formula
Molecular
weight
Area
(%)
Retention time
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O. tenuiflorum Camphene C10H16 136.24 32.42 9.83
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M. alba Napthelene C10H8 128.6 28.36 11.12
Hexadeconoic acid C16H32O2 256.4 40.76 14.23
9, 12-octadecadienic acid C17H31COOH 280.44 9.32 13.92
L. usitatisumum 2-cyclopentene-1-undecanoic
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